- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ambroxol Hydrochloride
Total 7331 results
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Agyany Pharma LTDRecruiting
-
Lawson Health Research InstituteNot yet recruiting
-
Shaare Zedek Medical CenterCompletedGaucher Disease, Type 1Israel
-
Boehringer IngelheimCompleted
-
University Medical Center GroningenRecruiting
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...University of Campania "Luigi Vanvitelli"; IRCCS National Neurological Institute...Active, not recruitingParkinson Disease | GBA Gene MutationItaly
-
Hallym University Kangnam Sacred Heart HospitalCompletedIn the Present Study, we Investigated the Effects of Oral Ambroxol on Tear Film and Ocular Surface.Korea, Republic of
-
University College, LondonNot yet recruiting
-
Hull University Teaching Hospitals NHS TrustSanofiCompleted
-
The Florey Institute of Neuroscience and Mental...The University of Queensland; Mobius Medical Pty Ltd.RecruitingAmyotrophic Lateral SclerosisAustralia
-
National University of MalaysiaCompletedCritical Illness | Hospital-acquired Pneumonia | Community-acquired Pneumonia | Severe PneumoniaMalaysia
-
Boehringer IngelheimCompleted
-
SanofiCompletedPharyngitisSouth Africa
-
Boehringer IngelheimCompleted
-
Ain Shams UniversityNot yet recruiting
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Hanmi Pharmaceutical Company LimitedCompleted
-
Lawson Health Research InstituteWestern University, Canada; London Health Sciences Centre; Weston Brain InstituteActive, not recruiting
-
Zambon SpACompletedRespiratory Tract Diseases | Abnormal Mucus SecretionsChina
-
Helse FonnaHelse-Bergen HF; KlinbeforskRecruitingDementia With Lewy BodiesNorway
-
Boehringer IngelheimCompleted
-
University College, LondonThe Cure Parkinson's TrustCompleted
-
Hyundai Pharmaceutical Co., LTD.Completed
-
Exsar CorporationSuspendedType I Gaucher DiseaseUnited States
-
Medical University of ViennaCompletedOcular Physiology | Autoregulation | Blood Flow VelocityAustria
-
Beijing Grand Johamu Pharmaceutical Company, Ltd.RecruitingCommunity-acquired PneumoniaChina
-
Boehringer IngelheimCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)SuspendedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Neelesh Sharma MD PhDCompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Xijing Hospital of Digestive DiseasesCompletedColorectal AdenomasChina
-
Xijing Hospital of Digestive DiseasesCompleted
-
Shenyang Sunshine Pharmaceutical Co., LTD.UnknownUremic PruritusChina
-
Galderma R&DCompleted
-
M.D. Anderson Cancer CenterWithdrawnMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8
-
Betta Pharmaceuticals Co., Ltd.Tigermed Consulting Co., LtdCompleted
-
EpygenixCompletedDravet SyndromeUnited States
-
Janssen Research & Development, LLCCompletedSexual Dysfunction, Physiological | EjaculationGermany, Spain, Portugal, Finland, Sweden, Austria
-
Advanz PharmaCompleted
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal Large B-Cell Lymphoma | Refractory Primary Mediastinal Large B-Cell LymphomaUnited States
-
Peking University Third HospitalNot yet recruitingNon-Small Cell Lung Cancer
-
WPD Pharmaceuticals Sp. z o.o.Worldwide Clinical TrialsNot yet recruiting
-
PhytoHealth CorporationCompleted
-
Zhejiang UniversityHuashan Hospital; West China Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsTerminatedHepatocellular CarcinomaChina
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
National Institute of Allergy and Infectious Diseases...International Tuberculosis Research CenterWithdrawnRefractory Pulmonary TuberculosisKorea, Republic of
-
Mundipharma K.K.CompletedRecurrent or Refractory T/NK-cell MalignanciesJapan